O025/#522 Maintenance olaparib rechallenge in patients with ovarian cancer previously treated with a parp inhibitor: patient-reported outcomes from the phase IIIB OReO/engot-ov38 trialAndrés Redondo,Philippe Follana,Giovanni Scambia,Bernard Asselain,Frederik Marmé,Mansoor Mirza,Maria Elena Laudani,Radosław Mądry,Rosalind Glasspool,Benoit You,María Jesús Rubio-Perez,Claudio Zamagni,Ahmed El-Balat,Anne Claire Hardy-Bessard,Ana Oaknin,Graziana Ronzino,Bob Shaw,Hitomi Nakamura,Dominique Berton,Eric Pujade-LauraineFocused Plenary Abstracts（2022）引用 0|浏览8暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
